Koninklijke BAM Groep nv (LON:0LNQ)
8.89
+0.00 (0.00%)
At close: Dec 12, 2025
Koninklijke BAM Groep nv Revenue
Koninklijke BAM Groep nv had revenue of 3.38B EUR in the half year ending June 30, 2025, with 13.84% growth. This brings the company's revenue in the last twelve months to 6.69B, up 5.11% year-over-year. In the year 2024, Koninklijke BAM Groep nv had annual revenue of 6.45B with 2.94% growth.
Revenue (ttm)
6.69B EUR
Revenue Growth
+5.11%
P/S Ratio
0.36
Revenue / Employee
511.05K EUR
Employees
13,082
Market Cap
2.06B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.45B | 184.48M | 2.94% |
| Dec 31, 2023 | 6.27B | -347.70M | -5.25% |
| Dec 31, 2022 | 6.62B | -697.11M | -9.53% |
| Dec 31, 2021 | 7.32B | 547.11M | 8.08% |
| Dec 31, 2020 | 6.77B | -407.79M | -5.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |